Old Web
English
Sign In
Acemap
>
authorDetail
>
Rebecca Lawrence
Rebecca Lawrence
Royal Melbourne Hospital
Imatinib
Medicine
Nilotinib
Mutation
Dasatinib
3
Papers
114
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sensitive Detection of BCR-ABL1 Mutations in Patients With Chronic Myeloid Leukemia After Imatinib Resistance Is Predictive of Outcome During Subsequent Therapy
2011
Journal of Clinical Oncology
Wendy T. Parker
Rebecca Lawrence
Musei Ho
Darryl Irwin
Hamish S. Scott
Timothy P. Hughes
Susan Branford
Show All
Source
Cite
Save
Citations (84)
The Initial Molecular Response of Chronic Phase CML Patients Treated with Second Generation ABL Inhibitor Therapy after Imatinib Failure Can Predict Inadequate Response and Provide Indications for Rational Mutation Screening
2008
Blood
Susan Branford
Rebecca Lawrence
Linda Fletcher
Chani Field
Zbigniew Rudzki
Timothy P. Hughes
Show All
Source
Cite
Save
Citations (13)
Long Term Follow up of Patients with CML in Chronic Phase Treated with First-Line Imatinib Suggests That Earlier Achievement of a Major Molecular Response Leads to Greater Stability of Response.
2008
Blood
Susan Branford
Rebecca Lawrence
Andrew Grigg
John F. Seymour
Anthony Schwarer
Christopher Arthur
Zbigniew Rudzki
Timothy Hughes
Show All
Source
Cite
Save
Citations (17)
1